KUMAR NAWANI

Valirx plc - We are a London Stock Exchange listed biopharmaceutical life sciences company on "AIM" since 2006 developing technologies and products in Oncology Therapeutics. Alongside an extensive family of Global IP rights, we are actively developing, managing & running phase 1/2 pre-clinical and full phase 1/2 clinical trials in the UK & in the EU. We also endeavour to look into global opportunities within the oncological and therapeutic arena with an aim to focus and endure collaborative opportunities to help support various global medical unmet needs. https://www.valirx.com | Stock Code: (VAL:LON)